HK1045266B - 用於治療由肉孢子蟲、新孢子蟲和弓形蟲引起的疾病的三嗪酮化合物 - Google Patents

用於治療由肉孢子蟲、新孢子蟲和弓形蟲引起的疾病的三嗪酮化合物

Info

Publication number
HK1045266B
HK1045266B HK02106846.1A HK02106846A HK1045266B HK 1045266 B HK1045266 B HK 1045266B HK 02106846 A HK02106846 A HK 02106846A HK 1045266 B HK1045266 B HK 1045266B
Authority
HK
Hong Kong
Prior art keywords
sarcosystis
neospora
toxoplasma
treating diseases
diseases due
Prior art date
Application number
HK02106846.1A
Other languages
English (en)
Other versions
HK1045266A1 (en
Inventor
J Kennedy Thomas
Original Assignee
美國拜爾公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美國拜爾公司 filed Critical 美國拜爾公司
Publication of HK1045266A1 publication Critical patent/HK1045266A1/xx
Publication of HK1045266B publication Critical patent/HK1045266B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK02106846.1A 1998-12-22 2002-09-19 用於治療由肉孢子蟲、新孢子蟲和弓形蟲引起的疾病的三嗪酮化合物 HK1045266B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/218,323 US6150361A (en) 1998-12-22 1998-12-22 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
PCT/US1999/030281 WO2000037063A2 (en) 1998-12-22 1999-12-18 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (2)

Publication Number Publication Date
HK1045266A1 HK1045266A1 (en) 2002-11-22
HK1045266B true HK1045266B (zh) 2006-07-07

Family

ID=22814646

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106846.1A HK1045266B (zh) 1998-12-22 2002-09-19 用於治療由肉孢子蟲、新孢子蟲和弓形蟲引起的疾病的三嗪酮化合物

Country Status (17)

Country Link
US (1) US6150361A (zh)
EP (1) EP1140103B1 (zh)
JP (1) JP2002532544A (zh)
KR (1) KR100661111B1 (zh)
CN (1) CN1221265C (zh)
AT (1) ATE302011T1 (zh)
AU (1) AU764608B2 (zh)
BR (1) BR9916391A (zh)
CA (1) CA2355825C (zh)
DE (1) DE69926794T2 (zh)
DK (1) DK1140103T3 (zh)
ES (1) ES2247863T3 (zh)
HK (1) HK1045266B (zh)
HU (1) HUP0104595A3 (zh)
NZ (1) NZ512477A (zh)
WO (1) WO2000037063A2 (zh)
ZA (1) ZA200103920B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914385A (pt) 1998-10-08 2001-07-17 New Ace Res Company Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
CA2407517A1 (en) * 2000-04-25 2001-11-01 Wyeth Equine protozoal myeloencephalitis vaccine
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
WO2024138230A1 (en) * 2022-12-02 2024-06-27 Veterinary Pharmacy Corporation Formulation and method for treatment of infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4933341A (en) * 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
BR9914385A (pt) * 1998-10-08 2001-07-17 New Ace Res Company Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais

Also Published As

Publication number Publication date
HK1045266A1 (en) 2002-11-22
KR100661111B1 (ko) 2006-12-26
US6150361A (en) 2000-11-21
JP2002532544A (ja) 2002-10-02
EP1140103A2 (en) 2001-10-10
WO2000037063A3 (en) 2000-10-19
DE69926794T2 (de) 2006-01-19
NZ512477A (en) 2004-05-28
DE69926794D1 (de) 2005-09-22
ES2247863T3 (es) 2006-03-01
ATE302011T1 (de) 2005-09-15
CN1342081A (zh) 2002-03-27
WO2000037063A2 (en) 2000-06-29
KR20010080570A (ko) 2001-08-22
CA2355825A1 (en) 2000-06-29
AU2481700A (en) 2000-07-12
BR9916391A (pt) 2001-09-18
HUP0104595A2 (hu) 2002-04-29
DK1140103T3 (da) 2005-12-19
AU764608B2 (en) 2003-08-28
ZA200103920B (en) 2002-05-15
CA2355825C (en) 2008-07-08
HUP0104595A3 (en) 2003-10-28
CN1221265C (zh) 2005-10-05
EP1140103B1 (en) 2005-08-17

Similar Documents

Publication Publication Date Title
HK1043315A1 (en) Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma.
IL172705A0 (en) Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
MXPA02008770A (es) Compuestos azaciclicos para uso en el tratamiento de enfermedades relacionadas con la serotonina.
LU91254I2 (fr) Daptomycine et ses dérivés pharmaceutiquement acceptables (cubicinr)
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
EA200100750A1 (ru) Способ лечения сексуальных нарушений
ATE303162T1 (de) Natrium kanalblocker zusammensetzungen und deren verwendung
MY119375A (en) Treatment of tinnitus using neuroprotective agents
HK1069339A1 (en) Substituted diketopiperazines as oxytocin antagonists
MXPA05003302A (es) Compuestos de piperazina terapeuticos.
HK1045266A1 (en) Triazineone compounds for treating diseases due tosarcosystis, neospora and toxoplasma
HK1024424A1 (en) Methods of therapeutic administration of anti-cd40l compounds
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
BR9916417A (pt) Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma
PT986393E (pt) Utilizacao de um nitroxido ou de um seu pro-farmaco no tratamento profilactico e terapeutico do cancro
EP1050303A3 (en) Methods and compositions for treating age-related behavioral disorders in companion animals
EP1056458A4 (en) METHODS FOR TREATING PAIN, INCLUDING CHRONIC AND WOMAN-SPECIFIC PAIN
HK1059894A1 (en) Praziquantel compounds for treating diseases due to sarcocystis, neospora, toxoplasma and isospora
WO2001007029A3 (en) Substituted guanidines and the use thereof
ATE248607T1 (de) Aminotetralin derivate zur therapie der kardiovaskulären erkrankungen
EA200200846A1 (ru) Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором
HUP9800835A3 (en) Pharmaceutical composition for treatment of diseases of honey-bees caused by ascophaera apis

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101218